Antihypertensive drugs Flashcards
Treatment for pts with chronic kidney disease
- ACE inhibitors
- Angiotensin receptor blocker (ARB)
Treatment for pts without chronic kidney disease
Black pts
- Thiazide diuretic
- calcium channel blocker
Nonblack
- Thiazide diuretic
- ACE inhibitor
- ARB
- CCB
Diuretics
Increase the rate of urine flow and Na excretion
- Used to adjust the volume and/or composition of body fluids in a variety of clinical situations
Carbonic anhydrase inhibitors
Acetazolamide
Loop diuretics
Ethacrynic acid
Furosemide (lasix)
Thiazide diuretics
Chlorthalidone
Hydrochlorothiazide
K sparing diuretics
Aldosterone antagonists
- Spironolactone
Epithelial Na channel inhibitors
- Amiloride
Acetazolamide
Inhibits carbonic anhydrase enzyme
Results in
- Decreased H formation inside PCT cell
- Decreased Na/H antiport
- Increased Na and HCO3 in lumen
Increased diuresis
Urine pH increased, body pH decreased
CI: glaucoma, altitude sickness, metabolic alkalosis
Furosemide and ethacrynic acid
Loop diuretics- inhibit the luminal Na/K/2Cl cotransporter in the TAL of henle
results in
- Decreased intracellular Na, K, Cl, in TAL
- Decrease back diffusion of K and positive potential
- Decreased reabsorption of Ca and Mg
Ion transport is virtually nonexistent, making it the most efficacious.
Increased diuresis.
Half-life correlated to kidney function.
Used for edematous states
Hydrochlorothiazide (HCTZ)
Thiazide diuretic- causes inhibition of the Na/Cl cotransporter
Results in
- Increased luminal Na and Cl in DCT
- Enhances the reabsorption of Ca in both DCT and PCT, why it is sometimes used for renal stones
Adverse effects- hyperGLUC
Mess with the body’s ability to regulate glucose levels
Spironolactone
K sparing diuretic, aldosterone receptor antagonist.
Can’t reabsorb Na and secrete K.
Uses: hyperaldosteronism, K depletion, HF
Do not require access to the tubular lumen to induce diuresis
Amiloride
K sparing diuretic, blocks the Na channels from absorbing, prevents K secretion
ACE inhibitors
Captopril
Enalapril
“pril”
ARBs
Losartan
Valsartan
“sartan”
Captropril and analapril
ACE inhibitors
Inhibit the conversion of ANG I to the more active ANG II. Also prevents degradation of bradykinin-vasodilator
Vasodilate the efferent arteriole- reduces back pressure on the glomerulus and reduces protein excretion
Benefits of ACE inhibitors
Cardiac function in pts w uncomplicated hypertension is little changed. Lowers TPR and mean, diastolic, and systolic BP
Baroreceptor function and cardiovascular reflexes are not compromised
Adverse effects of AVE inhibitors
Cough Angioedema Teratogen Creatinine (increased) Hyperkalemia- avoid K sparing diuretics Hypotension
Losartan and valsartan
Angiotensin II receptor blockers (AT1)
Selective block ANG II receptors, leads to
- Decreased contraction of vascular smooth muscle
- Decreased aldosterone secretion
- Decreased pressor responses
- Decreased cardiac cellular hypertrophy and hyperplasia
Effects similar to ACE inhibitors, but ARBs do not increase bradykinin
Aliskiren
Direct renin inhibitor
Does not increase bradykinin
Rise in plasma renin levels but decreased renin activity
Vasodilators: Calcium channel blockers- dihydropyridines
Amlodipine
Nifedipine
Vasodilators: Calcium channel blockers- non-dihydropyridines
Diltiazem
Verapamil
Vasodilator: Nitrix oxide donors
Hydralazine
Nitroprusside
Non-dihydropyridines
CCB
Prominent cardiac effects, but also act at vascular tissues.
Causes vasodilation.
Dihydropyridines
CCB
Predominantly arteriolar vasodilation effects
Verapamil
CCB
May cause constipation and peripheral edema
Use of verapamil with a B-blocker is contraindicated bc of the potential for AV block
Potassium channel openers
Increased potassium permeability stabilizes the smooth muscle cell membrane at resting potential, reducing the probability of contraction
- Diazoxide
- Minoxidil
Diazoxide
K channel opener
- Arteriolar vasodilation
- Diminishing use in hypertensive emergencies due to adverse efects
- Excessive hypotension can cause stroke and Mi
- Hyperglycemia
Minoxidil
K channel opener
- Arteriolar vasodilation
- Clinical uses include severe hypertension and baldness
Fenoldopam
Dopamine receptor agonist
- Activation increases blood flow to the kidneys
For HTN emergencies and post-operative HTN
Hydralazine
releases NO from endothelium- dilates arterioles, but not veins
First line oral therapy for hypertension in pregnancy